However, through a comprehensive meta-analysis of these 13 studies, we found that the levels of neurogenic exosome Aβ42, T-tau and P-tau181 in AD patients were significantly higher than those in healthy controls. The gene discussed is MAPT; the disease is Alzheimer disease.